相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
Huilin Shao et al.
NATURE COMMUNICATIONS (2015)
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Marina Colombo et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)
RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma
Xuebo Chen et al.
CANCER RESEARCH (2014)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Endothelial Secreted Factors Suppress Mitogen Deprivation-Induced Autophagy and Apoptosis in Glioblastoma Stem-Like Cells
Eva Maria Galan-Moya et al.
PLOS ONE (2014)
Extracellular vesicles: emerging targets for cancer therapy
Pieter Vader et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
The evolving landscape of glioblastoma stem cells
Kenneth Yan et al.
CURRENT OPINION IN NEUROLOGY (2013)
Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development
Paulina Kucharzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes
Rossella Crescitelli et al.
JOURNAL OF EXTRACELLULAR VESICLES (2013)
Semaphorin 3A elevates endothelial cell permeability through PP2A inactivation
Armelle Le Guelte et al.
JOURNAL OF CELL SCIENCE (2012)
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
Federica Maione et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma
Ashwatha Narayana et al.
JOURNAL OF NEUROSURGERY (2012)
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
Huilin Shao et al.
NATURE MEDICINE (2012)
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
Yuji Piao et al.
NEURO-ONCOLOGY (2012)
Glioblastoma Cell-Secreted Interleukin-8 Induces Brain Endothelial Cell Permeability via CXCR2
Julie Dwyer et al.
PLOS ONE (2012)
Differential Proteomic Analysis of Human Glioblastoma and Neural Stem Cells Reveals HDGF as a Novel Angiogenic Secreted Factor
Cecile Thirant et al.
STEM CELLS (2012)
Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models
Andrea Casazza et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer
Armelle Le Guelte et al.
BIOLOGY OF THE CELL (2011)
Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway
Eva Maria Galan-Moya et al.
EMBO REPORTS (2011)
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor
Lisette M. Acevedo et al.
BLOOD (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A perivascular niche for brain tumor stem cells
Christopher Calabrese et al.
CANCER CELL (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth
Qi Pan et al.
CANCER CELL (2007)
VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin
Julie Gavard et al.
NATURE CELL BIOLOGY (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Isolation of cancer stem cells from adult glioblastoma multiforme
XP Yuan et al.
ONCOGENE (2004)
分享论文
